Department of Otolaryngology-Head and Neck Surgery, Seoul Saint Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Department of Surgery, College of Medicine, Taif University, Taif 21944, Saudi Arabia.
Medicina (Kaunas). 2023 Mar 2;59(3):497. doi: 10.3390/medicina59030497.
: To assess the prognostic utilities of various risk factors for laryngeal squamous cell carcinoma. : Six databases were searched to January 2022. Hazard ratios for overall survival and disease-free survival were collected and study characteristics were recorded. The risk of bias was evaluated using the Newcastle-Ottawa scale. : Twenty-eight studies involving 32,128 patients were finally included. In terms of overall survival, older age, a history of alcohol consumption, a high Charlson comorbidity index score, a high TNM stage (III and IV), a high tumor stage (III and IV), nodal involvement, poor pathological differentiation, primary chemoradiotherapy and radiotherapy were associated with increased risks of death. In terms of disease-free survival, older age (≥60 years), TNM stages III and IV, tumor stages III and IV, supraglottic tumors, and nodal involvement all increased the risk of death. : The TNM stage importantly predicts overall survival, and tumor location predicts the disease-free survival of patients with laryngeal squamous cell carcinoma. Of patients with risk factors, the Charlson comorbidity index usefully predicts overall survival.
评估喉鳞状细胞癌各种危险因素的预后价值。从 2022 年 1 月开始,检索了六个数据库。收集了总生存率和无病生存率的风险比,并记录了研究特征。使用纽卡斯尔-渥太华量表评估偏倚风险。最终纳入了 28 项涉及 32128 名患者的研究。在总生存率方面,年龄较大、有饮酒史、Charlson 合并症指数评分较高、TNM 分期(III 期和 IV 期)较高、肿瘤分期(III 期和 IV 期)、淋巴结受累、病理分化差、原发放化疗和放疗均与死亡风险增加相关。在无病生存率方面,年龄较大(≥60 岁)、TNM 分期 III 和 IV、肿瘤分期 III 和 IV、声门上肿瘤和淋巴结受累均增加了死亡风险。TNM 分期对总生存率有重要预测作用,肿瘤位置对喉鳞状细胞癌患者的无病生存率有预测作用。对于有危险因素的患者,Charlson 合并症指数可有效预测总生存率。